Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yumi H. Maekawa"'
Autor:
Elizabete Delbuono, Yumi H. Maekawa, Maria do Rosário D. O. Latorre, Adriana Seber, Antonio Sergio Petrilli, Josefina A. P. Braga, Maria Lúcia M. Lee
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 30, Iss 4, Pp 281-286 (2008)
The detection of minimal residual disease (MRD) is an important prognostic factor in childhood acute lymphoblastic leukemia (ALL) providing crucial information on the response to treatment and risk of relapse. However, the high cost of these techniqu
Externí odkaz:
https://doaj.org/article/2b077f2e0e2b4a05a84c58f80c944e33
Autor:
Estela C. Ritter, Yumi H. Maekawa, Nair Tamashiro, Tânia T. Takao, Alex Freire Sandes, Cláudia Regina M.C. Oliveira, Maria de Lourdes Lopes Ferrari Chauffaille, Edgar Gil Rizzatti
Publikováno v:
Cytometry Part B: Clinical Cytometry. 86:98-105
Background: Multiparameter flow cytometry is a useful tool for the diagnostic evaluation of mature B-cell neoplasms (MBN). Recently, it has been shown that CD200 may improve the distinction between chronic lymphocytic leukemia (CLL; CD200+) and mantl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22141a0212489b6360a995cc56c7662f
https://doi.org/10.1002/cyto.b.21128
https://doi.org/10.1002/cyto.b.21128
Autor:
Maria de Lourdes Lopes Ferrari Chauffaille, Thais Elisa S. Miura, Alex Freire Sandes, Iracema Nunes de Castro, Yumi H. Maekawa, Edgar Gil Rizzatti, Ana Paula Cozac
Publikováno v:
Journal of Hematopathology. 4:123-126
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy derived from clonal proliferation of plasmacytoid dendritic cells. The disease has two patterns of presentation: cutaneous and leukemic. Herein we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b12dfef1e9ca035b5fa28d76803be45
https://doi.org/10.1007/s12308-011-0097-5
https://doi.org/10.1007/s12308-011-0097-5
Autor:
Yumi H. Maekawa, Adriana Bruscato Bortoluzzo, Bruna Raphaeli Silva, Ana Carolina de Carvalho, Gisele W. B. Colleoni, Edgar Gil Rizzatti, Walter Moises Tobias Braga, Djordje Atanackovic
Publikováno v:
Cancer Immunology, Immunotherapy
Introduction Multiple myeloma (MM) development involves a series of genetic abnormalities and changes in the bone marrow (BM) microenvironment, favoring the growth of the tumor and failure of local immune control. T regulatory (Treg) cells play an im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66c784a11990e435b3e6cc2aa5d57710
https://pubmed.ncbi.nlm.nih.gov/25099367
https://pubmed.ncbi.nlm.nih.gov/25099367
Autor:
Josefina A. P. Braga, E. Delbuono, Yumi H. Maekawa, Maria Lúcia M. Lee, Adriana Seber, Maria do Rosário Dias de Oliveira Latorre, Antonio Sergio Petrilli
Publikováno v:
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) A detecção de doença residual mínima (DRM) é um importante fator prognóstico na leucemia linfóide aguda (LLA) infantil e fornece informações sobre a resposta ao tratamento e o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d713241b99b76ed0a2d4378c3e8bd9bd
https://doi.org/10.1590/s1516-84842008000400010
https://doi.org/10.1590/s1516-84842008000400010
Autor:
Irina Yoco Takihi, Maria de Lourdes Lopes Ferrari Chauffaille, Thais Elisa S. Miura, Edgar Gil Rizzatti, Yumi H. Maekawa, Alex Freire Sandes
Publikováno v:
Molecular Genetics and Metabolism. 110:414-415
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9f4998dbee45770a0ee0ac388d0c03a
https://doi.org/10.1016/j.ymgme.2013.08.001
https://doi.org/10.1016/j.ymgme.2013.08.001
Autor:
José Salvador Oliveira, Marco Antonio Zago, Maria de Lourdes Lopes Ferrari Chauffaille, Zelia R. Andrade, Arnon Nagler, Adrian Wiestner, Yumi H. Maekawa, Edgar Gil Rizzatti, Valdemir Melechco Carvalho, Rodrigo Proto-Siqueira, Melina G. Santos, Leonardo A. Testagrossa
Publikováno v:
Blood. 116:773-773
Abstract 773 Mantle cell lymphoma (MCL) remains an incurable disease and has the worst outcome among B-cell lymphomas. Patients generally have a good response to first line treatment but most relapse and tend to have shorter responses or resistant di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d2ac6e2a6e7efd249197f5d806ab692
https://doi.org/10.1182/blood.v116.21.773.773
https://doi.org/10.1182/blood.v116.21.773.773
Autor:
Braga, Walter, Silva, Bruna, Carvalho, Ana, Maekawa, Yumi, Bortoluzzo, Adriana, Rizzatti, Edgar, Atanackovic, Djordje, Colleoni, Gisele
Publikováno v:
Cancer Immunology, Immunotherapy; Nov2014, Vol. 63 Issue 11, p1189-1197, 9p